AI Tool Valued at $12 Billion, Doubling Founder’s Fortune, Quietly Transforming US Medical Industry
The AI search tool for doctors, OpenEvidence, has completed a new round of financing at a valuation of $12 billion.…
The AI search tool for doctors, OpenEvidence, has completed a new round of financing at a valuation of $12 billion.…
• 16 minutes ago • 3 Mins Read The Series D round reflects growing investor appetite for artificial intelligence tools…
Medical AI startup OpenEvidence has raised $250 million in fresh funding at a $12 billion valuation, doubling its value in…
OpenEvidence Inc., a startup that develops artificial intelligence software for physicians, today disclosed that it has raised $250 million in…
Daniel Nadler, CEO and cofounder of OpenEvidence, an AI search tool for doctors, doubled his net worth to $7.6 billion…
Jan 21 (Reuters) – OpenEvidence, an AI startup whose tools are used by U.S. physicians, has raised $250 million in…
OpenEvidence just doubled its valuation in three months. The medical AI platform announced a $250 million Series D at $12…
VCs who have backed OpenEvidence are apparently not worried about new health information products from OpenAI and Anthropic. On Wednesday,…
OpenEvidence, an artificial intelligence (AI) startup described as “ChatGPT for doctors”, has raised new funding that values the company at…
OpenEvidence, an artificial intelligence (AI) startup described as “ChatGPT for doctors”, has raised new funding that values the company at…
In the fast-evolving world of artificial intelligence applied to healthcare, few stories capture the imagination quite like that of OpenEvidence.…
OpenEvidence Inc., the developer of an artificial intelligence search engine for doctors, today announced that it has closed a $200…
OpenEvidence announced today its acquisition of Amaro, an AI-native advertising company founded by Kush Khosla and Sauren Khosla and backed by…
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The Surf Club…